LSA
BHVN

L & S Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

L & S Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,870
Closed -$272K – 269
2022
Q2 		$272K Sell
1,870
-24,064
-93% -$3.07M 0.05% 193
2022
Q1 		$3.08M Sell
25,934
-16,544
-39% -$2.06M 0.36% 78
2021
Q4 		$5.85M Sell
42,478
-11,647
-22% -$1.48M 0.63% 46
2021
Q3 		$7.52M Sell
54,125
-7,669
-12% -$958K 0.81% 30
2021
Q2 		$6M Buy
61,794
+2,983
+5% +$242K 0.65% 38
2021
Q1 		$4.02M Sell
58,811
-1,465
-2% -$118K 0.46% 72
2020
Q4 		$5.17M Sell
60,276
-2,284
-4% -$194K 0.6% 50
2020
Q3 		$4.07M Sell
62,560
-6,003
-9% -$393K 0.56% 64
2020
Q2 		$5.01M Sell
68,563
-44,688
-39% -$2.38M 0.75% 41
2020
Q1 		$3.85M Buy
113,251
+47,718
+73% +$2.18M 0.73% 30
2019
Q4 		$3.57M Buy
65,533
+5,407
+9% +$268K 0.46% 55
2019
Q3 		$2.51M Sell
60,126
-21,742
-27% -$919K 0.35% 86
2019
Q2 		$3.58M Buy
81,868
+39,446
+93% +$2.22M 0.47% 60
2019
Q1 		$2.18M Sell
42,422
-1,718
-4% -$74.2K 0.29% 84
2018
Q4 		$1.63M Buy
44,140
+17,625
+66% +$635K 0.31% 63
2018
Q3 		$996K Buy
26,515
+5,830
+28% +$214K 0.13% 144
2018
Q2 		$817K Buy
+20,685
New +$656K 0.14% 151

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

L & S Advisors's BHVN Position: Q3 2022 in Review

L & S Advisors sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 1,870 shares — an estimated $272K sold.

L & S Advisors first reported a position in BHVN in Q2 2018 and held it in 17 quarters. The position peaked at $7.52M in Q3 2021. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • L & S Advisors reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • L & S Advisors sold 1,870 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $272K.
  • L & S Advisors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2018 and held it in 17 quarters.
  • L & S Advisors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $7.52M in Q3 2021.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on L & S Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.